The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network

Vincenzo de Sanctis^*, Ashraf Soliman, Ploutarchos Tzoulis, Shahina Daar, Antonis Kattamis, Polyxeni Delaporta, Mehran Karimi, Mohamed A. Yassin, Tahereh Zarei, Forough Saki, Katia Sapunarova, Atanas Banchev, Maria Concetta Galati, Giuseppe Raiola, Giuseppe Messina, Saveria Campisi, Christos Kattamis